Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$58.16 - $75.44 $14,947 - $19,388
-257 Reduced 6.49%
3,703 $272,000
Q3 2023

Nov 08, 2023

SELL
$70.9 - $88.63 $26,871 - $33,590
-379 Reduced 8.73%
3,960 $283,000
Q2 2023

Jul 31, 2023

SELL
$81.09 - $94.16 $11,758 - $13,653
-145 Reduced 3.23%
4,339 $378,000
Q1 2023

May 12, 2023

BUY
$82.98 - $91.46 $10,206 - $11,249
123 Added 2.82%
4,484 $400,000
Q4 2022

Jan 19, 2023

SELL
$66.93 - $97.5 $18,071 - $26,325
-270 Reduced 5.83%
4,361 $374,000
Q3 2022

Nov 01, 2022

BUY
$69.86 - $107.63 $16,067 - $24,754
230 Added 5.23%
4,631 $331,000
Q2 2022

Jul 29, 2022

BUY
$89.06 - $117.64 $391,953 - $517,733
4,401 New
4,401 $428,000

Others Institutions Holding QDEL

About QuidelOrtho Corp


  • Ticker QDEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 66,952,900
  • Market Cap $2.74B
  • Description
  • QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...
More about QDEL
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.